Holekamp, Nancy M <br/><br/>
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration.  [electronic resource] 

 -  American journal of ophthalmology  Apr 2014 
 - 825-833.e1 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-1891 
<br/><br/><label>Standard No.: </label>10.1016/j.ajo.2013.12.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Bevacizumab<br/>Databases, Factual<br/>Drug Utilization--statistics & numerical data<br/>Female<br/>Fluorescein Angiography<br/>Humans<br/>Insurance Claim Review<br/>Intravitreal Injections<br/>Male<br/>Medicare Part B<br/>Ranibizumab<br/>Retreatment<br/>Retrospective Studies<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>United States<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--physiology<br/>Wet Macular Degeneration--diagnosis